Tactics of anticoagulant therapy in patients with cardiac implantable electronic devices and subclinical atrial fibrillation: A review

Screening for atrial fibrillation (AF) has attracted considerable attention recently. Of special interest are patients with cardiac implantable electronic devices (CIEDs) that allow recording episodes of arrhythmias various durations, including asymptomatic ones, in which case they referred to as subclinical (SCAF). The available data suggest the risk thromboembolic events varies between SCAF and clinically overt AF. As today, question regarding anticoagulant therapy remains unresolved. article presents an overview previous ongoing studies on this issue, well current guidelines use CIEDs.